Is periostin useful as a biomarker for fibrous dysplasia?
Actual. osteol; 18 (1), 2022
Fibrous dysplasia (FD) is an infrequent non-hereditary bone disease caused by a somatic mutation of the GNAS gene. Periostin is a novel marker that increases during tissue healing and fibrous or inflammatory diseases. We conducted an exploratory case-control study to eval...